Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
February 18 2025 - 4:21PM
Edgar (US Regulatory)
Exhibit 99.1
Covered Persons
Roivant has a board of directors and executive officers (such individuals, collectively, the "Covered Persons"). The name, present principal occupation and country of citizenship
of each of the Covered Persons is set forth below, along with the principal business address of the employer of each of the Covered Persons.
|
Name
|
|
Principal Business
Address of Employer
|
|
Present Principal Occupation
|
|
Citizenship
|
| |
|
|
|
|
|
|
|
Matthew Gline
|
|
c/o Roivant Sciences Ltd., 7th Floor, 50 Broadway
London SW1H 0DB
United Kingdom
|
|
Director and Principal Executive Officer, Roivant Sciences Ltd.; Chief Executive Officer, Roivant Sciences, Inc.
|
|
United States
|
| |
|
|
|
|
|
|
|
Keith Manchester
|
|
888 Seventh Avenue, 43rd Floor, New York, NY 10106
|
|
Partner and the Head of Life Sciences, QVT Financial LP
|
|
United States
|
| |
|
|
|
|
|
|
|
Melissa Epperly
|
|
c/o Roivant Sciences Ltd., 7th Floor, 50 Broadway
London SW1H 0DB
United Kingdom
|
|
Healthcare Executive
|
|
United States
|
| |
|
|
|
|
|
|
|
Daniel Gold
|
|
888 Seventh Avenue, 43rd Floor, New York, NY 10106
|
|
Founder and Chief Executive Officer of QVT Financial LP
|
|
United States
|
| |
|
|
|
|
|
|
|
Meghan FitzGerald
|
|
c/o Roivant Sciences Ltd., 7th Floor, 50 Broadway
London SW1H 0DB
United Kingdom
|
|
Director, Tenet Healthcare; Founder, K2HealthVentures; Adjunct Professor of Health Policy at Columbia University
|
|
United States
|
| |
|
|
|
|
|
|
|
James C. Momtazee
|
|
2884 Sand Hill Rd #100, Menlo Park, CA 94025
|
|
Managing Partner, Patient Square Capital
|
|
United States
|
| |
|
|
|
|
|
|
|
Ilan Oren
|
|
1 Dexcel Street, Or Akiva, 3060000, Israel
|
|
Co-Chief Executive Officer, Dexcel Pharma
|
|
Israel
|
| |
|
|
|
|
|
|
|
Mayukh Sukhatme
|
|
c/o Roivant Sciences Ltd., 7th Floor, 50 Broadway
London SW1H 0DB
United Kingdom
|
|
Director, Roivant Sciences Ltd.; President and Chief Investment Officer, Roivant Sciences, Inc.
|
|
United States
|
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Feb 2024 to Feb 2025
